FastLine

Technology Developed by:
MESH Incubator
Company Status:
MESH Incubator Portfolio Company
Intellectual Property Status:
Owned by MESH Incubator/Mass General Brigham
IP Available for License?:
Yes
Company/Technology Summary:

FastLine allows the user to perform all the steps of percutaneous access for central line placement with one hand using a consolidated single-hand device to improve the safety and efficiency of central line placement.

Two of our co-founders, Hilary and Graham, are physicians who practice at MGH. Hilary, an anesthesiologist, frequently performs central line procedures. After witnessing multiple instances of iatrogenic injury from central line placements gone wrong, she thought “there has to be a better way to do this.” After sharing the pain point with Graham while they were both on call, they started to research and ideate together. They found that 1 in 10 central line procedures result in mechanical complications that harm the patient, and that these complications cost over $2BN per year to manage. The addition of ultrasound has reduced the complication rate somewhat, but the procedural techniques and tools have largely remained unchanged for decades and was never designed to fully incorporate ultrasonic guidance. Recognizing the opportunity to innovate and improve patient outcomes, FastLine was born.